ROR1 and breast carcinoma: Our RNA-seq analysis of HGSOC tumor samples identified increased ROR1 expression in post-NACT samples, consistent with previous findings on the therapeutic modulation of ROR1, notably by glucocorticoid-enriched NACT that could induce ROR1 expression in OC cells and a ROR1-dependent metastatic development in breast cancer, respectively [18, 24].